CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 8 filers reported holding CHINA PHARMA HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,196 | -26.8% | 22,900 | -0.4% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 23,000 | -2.5% | 0.00% | – |
| Q2 2022 | $5,000 | -54.5% | 23,600 | -15.7% | 0.00% | – |
| Q1 2022 | $11,000 | -26.7% | 28,000 | -11.4% | 0.00% | – |
| Q4 2021 | $15,000 | +87.5% | 31,600 | +122.5% | 0.00% | – |
| Q3 2021 | $8,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 2,104,826 | $632,000 | 0.51% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,290,463 | $387,000 | 0.07% |
| GLENHILL ADVISORS LLC | 200,000 | $60,000 | 0.01% |
| Renaissance Technologies | 136,300 | $41,000 | 0.00% |
| Virtu KCG Holdings LLC | 19,910 | $6,000 | 0.00% |
| UBS Group AG | 5,618 | $2,000 | 0.00% |